Tempus AI (TEM) Projected to Post Earnings on Monday

Tempus AI (NASDAQ:TEM) will likely be releasing its earnings data before the market opens on Monday, February 3rd. Analysts expect Tempus AI to post earnings of ($0.14) per share and revenue of $200,550.00 billion for the quarter.

Tempus AI Price Performance

Shares of NASDAQ TEM opened at $51.40 on Monday. Tempus AI has a twelve month low of $22.89 and a twelve month high of $79.49. The company has a debt-to-equity ratio of 8.17, a current ratio of 2.69 and a quick ratio of 2.55. The firm has a 50-day moving average of $44.36 and a two-hundred day moving average of $47.77.

Insider Activity

In related news, CEO Eric P. Lefkofsky sold 85,788 shares of the business’s stock in a transaction that occurred on Friday, January 24th. The stock was sold at an average price of $53.39, for a total value of $4,580,221.32. Following the completion of the transaction, the chief executive officer now directly owns 5,771,787 shares in the company, valued at approximately $308,155,707.93. The trade was a 1.46 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Andrew Polovin sold 51,504 shares of the firm’s stock in a transaction that occurred on Wednesday, December 11th. The stock was sold at an average price of $42.39, for a total transaction of $2,183,254.56. Following the sale, the executive vice president now owns 246,085 shares in the company, valued at $10,431,543.15. This trade represents a 17.31 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 1,862,758 shares of company stock valued at $79,585,675 in the last ninety days.

Analysts Set New Price Targets

A number of brokerages have recently weighed in on TEM. Piper Sandler reiterated a “neutral” rating and set a $70.00 price target (up previously from $40.00) on shares of Tempus AI in a report on Tuesday, November 12th. Bank of America raised their target price on Tempus AI from $52.00 to $54.00 and gave the company a “neutral” rating in a report on Friday, December 13th. Guggenheim initiated coverage on shares of Tempus AI in a report on Monday, December 9th. They set a “buy” rating and a $74.00 price objective for the company. Wolfe Research assumed coverage on Tempus AI in a report on Friday, December 13th. They issued an “outperform” rating and a $60.00 target price on the stock. Finally, Needham & Company LLC restated a “buy” rating and set a $56.00 price objective on shares of Tempus AI in a report on Tuesday, January 14th. Three equities research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. According to MarketBeat, Tempus AI has an average rating of “Moderate Buy” and an average price target of $56.36.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.